49
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

TARGETED THERAPY OF RESPIRATORY SYNCYTIAL VIRUS BY 2-5A ANTISENSE

, , &
Pages 497-501 | Published online: 15 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ravinder Malik & Ipsita Roy. (2008) Design and development of antisense drugs. Expert Opinion on Drug Discovery 3:10, pages 1189-1207.
Read now

Articles from other publishers (4)

Marie-Claude Rouan, Tom Gevers, Dirk Roymans, Loeckie de Zwart, David Nauwelaers, Marc De Meulder, Pieter van Remoortere, Marc Vanstockem, Anil Koul, Kenny Simmen & Koen Andries. (2010) Pharmacokinetics-Pharmacodynamics of a Respiratory Syncytial Virus Fusion Inhibitor in the Cotton Rat Model. Antimicrobial Agents and Chemotherapy 54:11, pages 4534-4539.
Crossref
Shen-Hao Lai, David A Stein, Antonieta Guerrero-Plata, Sui-Ling Liao, Teodora Ivanciuc, Chao Hong, Patrick L Iversen, Antonella Casola & Roberto P Garofalo. (2008) Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice. Molecular Therapy 16:6, pages 1120-1128.
Crossref
Rahul K. Nath, Weijun Xiong, Andrea D. Humphries & Rajinder Beri. (2007) Treatment With Antisense Oligonucleotide Reduces the Expression of Type I Collagen in a Human-Skin Organ-Wound Model. Annals of Plastic Surgery 59:6, pages 699-706.
Crossref
Robert W. Sidwell & Dale L. Barnard. (2006) Respiratory syncytial virus infections: Recent prospects for control. Antiviral Research 71:2-3, pages 379-390.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.